Accolade Stock Forecast, Price & News

12 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Accolade in the last year. There are currently 1 hold rating and 11 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Accolade stock.
View analyst ratings for Accolade or view top-rated stocks.

Wall Street analysts have given Accolade a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Accolade wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Accolade is scheduled to release its next quarterly earnings announcement on Wednesday, August 11th 2021.
View our earnings forecast for Accolade.

Accolade, Inc. (NASDAQ:ACCD) posted its earnings results on Tuesday, May, 4th. The company reported ($0.22) earnings per share for the quarter, missing the Zacks' consensus estimate of ($0.10) by $0.12. The business earned $59.23 million during the quarter, compared to the consensus estimate of $55.38 million. Accolade had a negative net margin of 29.73% and a negative trailing twelve-month return on equity of 27.59%. The company's revenue was up 33.3% on a year-over-year basis.
View Accolade's earnings history.

Accolade issued an update on its first quarter 2022 earnings guidance on Wednesday, May, 26th. The company provided earnings per share guidance of - for the period. The company issued revenue guidance of $54 million-$56 million, compared to the consensus revenue estimate of $53.43 million.

12 equities research analysts have issued 12-month price targets for Accolade's stock. Their forecasts range from $39.00 to $62.00. On average, they anticipate Accolade's share price to reach $54.92 in the next twelve months. This suggests a possible upside of 1.9% from the stock's current price.
View analysts' price targets for Accolade or view top-rated stocks among Wall Street analysts.

152 employees have rated Accolade CEO Rajeev Singh on Glassdoor.com. Rajeev Singh has an approval rating of 74% among Accolade's employees.

Some companies that are related to Accolade include Worldline (WWLNF), The Western Union (WU), Nielsen (NLSN), WEX (WEX), Concentrix (CNXC), Shift4 Payments (FOUR), Fiverr International (FVRR), CDK Global (CDK), HealthEquity (HQY), Ritchie Bros. Auctioneers (RBA), OLO (OLO), MultiPlan (MPLN), Grubhub (GRUB), Maximus (MMS) and Alliance Data Systems (ADS).
View all of ACCD's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Accolade investors own include Honeywell International (HON), CVS Health (CVS), Johnson & Johnson (JNJ), Raytheon Technologies (RTX), Alibaba Group (BABA), The Home Depot (HD), The Procter & Gamble (PG), Thermo Fisher Scientific (TMO), Cisco Systems (CSCO) and Intel (INTC).

(ACCD) raised $176 million in an initial public offering (IPO) on Thursday, July 2nd 2020. The company issued 8,800,000 shares at a price of $19.00-$21.00 per share. Goldman Sachs, Morgan Stanley and BofA Securities served as the underwriters for the IPO and Piper Sandler, Credit Suisse, William Blair, Baird and SVB Leerink were co-managers.

Accolade trades on the NASDAQ under the ticker symbol "ACCD."

Accolade's stock is owned by a variety of institutional and retail investors. Top institutional investors include ARK Investment Management LLC (9.05%), Select Equity Group L.P. (3.47%), BlackRock Inc. (3.47%), Gilder Gagnon Howe & Co. LLC (3.23%), JPMorgan Chase & Co. (3.01%) and Bellevue Group AG (2.81%).
View institutional ownership trends for Accolade.

ACCD stock was sold by a variety of institutional investors in the last quarter, including Perceptive Advisors LLC, Ameriprise Financial Inc., JPMorgan Chase & Co., Eaton Vance Management, Provenire Capital LLC, Quantbot Technologies LP, Bank of Montreal Can, and Tudor Investment Corp Et Al.
View insider buying and selling activity for Accolade or view top insider-selling stocks.

ACCD stock was purchased by a variety of institutional investors in the last quarter, including ARK Investment Management LLC, University of Texas Texas AM Investment Managment Co., Bellevue Group AG, Select Equity Group L.P., BlackRock Inc., Sectoral Asset Management Inc, Blackstone Group Inc., and Blackstone Group Inc..
View insider buying and selling activity for Accolade or or view top insider-buying stocks.

Shares of ACCD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of ACCD stock can currently be purchased for approximately $53.88.

Accolade has a market capitalization of $3.16 billion and generates $170.36 million in revenue each year. The company earns $-50,650,000.00 in net income (profit) each year or ($1.65) on an earnings per share basis.

Accolade employs 1,720 workers across the globe.

The official website for Accolade is accolade.com.

Accolade is headquartered at 660 W. GERMANTOWN PIKE SUITE 500, PLYMOUTH MEETING PA, 19462.

Accolade's mailing address is 660 W. GERMANTOWN PIKE SUITE 500, PLYMOUTH MEETING PA, 19462. The company can be reached via phone at 347-574-3820 or via email at [email protected]